Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure (AMAZE 3)
Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure (AMAZE 3)
This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated with positive airway pressure lose weight and improve sleep apnoea. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it) and which treatment participants get is decided by chance.
Key Inclusion Criteria:
Key Exclusion Criteria:
clinicaltrials@novonordisk.com(+1) 866-867-7178
DuBois, Pennsylvania 15801, United States
Houston, Texas 77089, United States
South Brisbane, Queensland 4101, Australia
Crawley, Western Australia 6009, Australia
Beijing, Beijing Municipality 100044, China
Nanjing, Jiangsu 210011, China
Suzhou, Jiangsu 215006, China
Zhenjiang, Jiangsu 212001, China
Vijayawada, Andhra Pradesh 520008, India
Bhubaneswar, Odisha 751019, India
Wroclaw, Dolnoslaskie Voivodeship 50-981, Poland
Krakow, 30-901, Poland
Warsaw, 01-138, Poland
Alanya/ Antalya, 07400, Turkey (Türkiye)
Maltepe/İstanbull, 34843, Turkey (Türkiye)
Merkez/Battalgazi/Malatya, 44280, Turkey (Türkiye)
Merkez/Çorum, 19040, Turkey (Türkiye)
Yenimahalle / Ankara, 06170, Turkey (Türkiye)
Yuregir/Adana, 01060, Turkey (Türkiye)
Yıldırım/Bursa, 16310, Turkey (Türkiye)
Zeytinburnu/İstanbul, 34020, Turkey (Türkiye)